FindTrial
Sign In

A cohort study of the performance of ASpirin-FREE therapy after successful percutaneous coronary intervention for acute coronary syndrome

A cohort study of the performance of ASpirin-FREE therapy after successful percutaneous coronary intervention for acute coronary syndrome: the ASFREE pilot study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0008182
Enrollment
200
Registered
2023-02-14
Start date
2022-11-20
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Wonkwang University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients who successfully received a drug-eluting stent after diagnosis of acute coronary syndrome 2. Patients who voluntarily participated in this study and gave written consent

Exclusion criteria

Exclusion criteria: 1. Age less than 19 years 2. Contraindications to prasugrel or ticagrelor: history of intracranial hemorrhage, active bleeding, etc. 3. Subjects whose life expectancy is less than 1 year 4. Subjects who are judged unsuitable by investigators

Design outcomes

Primary

MeasureTime frame
Incidence of stent thrombosis—

Secondary

MeasureTime frame
Target vessek failure—

Countries

Korea, Republic of

Contacts

Public ContactKyeong Ho Yun

Wonkwang University Hospital

dryunkh@gmail.com+82-63-859-2524

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026